Compositions and methods for the therapy and diagnosis of...

Details Compositions and methods for the therapy and diagnosis of... Compositions and methods for the therapy and diagnosis of...

2008-11-12

2011-11-15

Mosher, Mary E. (Department: 1648)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

C424S204100, C530S388150, C530S388300, C435S005000

Reexamination Certificate

active

08057796

ABSTRACT:
The present invention provides novel human anti-influenza antibodies and related compositions and methods. These antibodies are used in the diagnosis and treatment of influenza infection.

REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 3896111 (1975-07-01), Kupchan et al.
patent: 4137230 (1979-01-01), Hashimoto et al.
patent: 4151042 (1979-04-01), Higashide et al.
patent: 4248870 (1981-02-01), Miyashita et al.
patent: 4256746 (1981-03-01), Miyashita et al.
patent: 4260608 (1981-04-01), Miyashita et al.
patent: 4265814 (1981-05-01), Hashimoto et al.
patent: 4294757 (1981-10-01), Asai
patent: 4307016 (1981-12-01), Asai et al.
patent: 4308268 (1981-12-01), Miyashita et al.
patent: 4308269 (1981-12-01), Miyashita et al.
patent: 4309428 (1982-01-01), Miyashita et al.
patent: 4313946 (1982-02-01), Powell et al.
patent: 4315929 (1982-02-01), Freedman et al.
patent: 4317821 (1982-03-01), Miyashita et al.
patent: 4322348 (1982-03-01), Asai et al.
patent: 4331598 (1982-05-01), Hasegawa et al.
patent: 4361650 (1982-11-01), Asai et al.
patent: 4362663 (1982-12-01), Kida et al.
patent: 4364866 (1982-12-01), Asai et al.
patent: 4371533 (1983-02-01), Akimoto et al.
patent: 4424219 (1984-01-01), Hashimoto et al.
patent: 4450254 (1984-05-01), Isley et al.
patent: 4485045 (1984-11-01), Regen
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4554101 (1985-11-01), Hopp
patent: 4676980 (1987-06-01), Segal et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4975278 (1990-12-01), Senter et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5053394 (1991-10-01), Ellestad et al.
patent: 5208020 (1993-05-01), Chari et al.
patent: 5229275 (1993-07-01), Goroff
patent: 5416064 (1995-05-01), Chari et al.
patent: 5500362 (1996-03-01), Robinson et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5567610 (1996-10-01), Borrebaeck et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5571894 (1996-11-01), Wels et al.
patent: 5587458 (1996-12-01), King et al.
patent: 5591669 (1997-01-01), Krimpenfort et al.
patent: 5627052 (1997-05-01), Schrader
patent: 5641870 (1997-06-01), Rinderknecht et al.
patent: 5648237 (1997-07-01), Carter
patent: 5712374 (1998-01-01), Kuntsmann et al.
patent: 5714586 (1998-02-01), Kunstmann et al.
patent: 5739116 (1998-04-01), Hamann et al.
patent: 5739277 (1998-04-01), Presta et al.
patent: 5767285 (1998-06-01), Hamann et al.
patent: 5770701 (1998-06-01), McGahren et al.
patent: 5770710 (1998-06-01), McGahren et al.
patent: 5773001 (1998-06-01), Hamann et al.
patent: 5789199 (1998-08-01), Joly et al.
patent: 5821337 (1998-10-01), Carter et al.
patent: 5837234 (1998-11-01), Gentile et al.
patent: 5840523 (1998-11-01), Simmons et al.
patent: 5877296 (1999-03-01), Hamann et al.
patent: 6331415 (2001-12-01), Cabilly et al.
patent: 6824780 (2004-11-01), Devaux et al.
patent: 7112439 (2006-09-01), Johnson et al.
patent: 2003/0219442 (2003-11-01), Mikayama et al.
patent: 2005/0170334 (2005-08-01), Mikayama et al.
patent: 2010/0178295 (2010-07-01), Grandea et al.
patent: 73657 (1983-03-01), None
patent: 183070 (1986-06-01), None
patent: 244234 (1987-11-01), None
patent: 402226 (1990-12-01), None
patent: 404097 (1990-12-01), None
patent: 0425235 (1991-05-01), None
patent: WO-8101145 (1981-04-01), None
patent: WO-8807378 (1988-10-01), None
patent: WO-9013646 (1990-11-01), None
patent: WO-9100360 (1991-01-01), None
patent: WO-9202551 (1992-02-01), None
patent: WO-9220373 (1992-11-01), None
patent: WO-9308829 (1993-05-01), None
patent: WO-9311161 (1993-06-01), None
patent: WO-9316185 (1993-08-01), None
patent: WO-9321232 (1993-10-01), None
patent: WO-9404690 (1994-03-01), None
patent: WO 94/09136 (1994-04-01), None
patent: WO-9411026 (1994-05-01), None
patent: WO-9607321 (1996-03-01), None
patent: WO-9616673 (1996-06-01), None
patent: WO-9717852 (1997-05-01), None
patent: WO-9738731 (1997-10-01), None
patent: WO-9802463 (1998-01-01), None
patent: WO 03/078600 (2003-09-01), None
patent: WO 2006/061723 (2006-06-01), None
patent: WO 2007/031550 (2007-03-01), None
patent: WO 2007/150020 (2007-12-01), None
patent: WO-2009/064805 (2009-05-01), None
patent: WO-2010/063675 (2010-06-01), None
Madec et al., Four IgG Anti-Islet Human Monoclonal Antibodies Isolated from a Type 1 Diabetes Patient Recognize Distinct Epitopes of Glutamic Acid Decarboxylase 65 and Are Somatically Mutated, 1996, Journal of Immunology, vol. 156, pp. 3541-3549.
Vajdos et al., Comprehensive Functional Maps of the Antigen binding Site of an Anti-ErbB2 Antibody Obtained with Shotgun Scanning Mutagenesis, 2002, Journal of Molecular Biology, vol. 320, pp. 415-428.
De Filette et al., “An influenza A vaccine based on tetrameric ectodomain of matrix protein 2”,J. Biol. Chem.,283(17):11382-11387 (2008).
Feng et al., “Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2”,Virology J.,3(1):102 (2006).
Zhang et al., “Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus”,Mol. Immunol.,43(14):2195-2206 (2006).
International Search Report for PCT/US2008/083265, mailed Mar. 30, 2009.
Ito et al., “Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins”,J. Virol.,65(10):5491-5498 (1991).
Lamb et al., “Influenza virus M2protein is an integral membrane protein expressed on the infected-cell surface”,Cell,40:627-633 (1985).
Zebedee et al., “Influenza A virus M2protein: monoclonal antibody restriction of virus growth and detection of M2in virions”,J. Virol.,62(8):2762-2772 (1988).
Altschul et al., “Basic Local Alignment Search Tool”,J. Mol. Biol.,215:403-410 (1990).
Altschul et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs”,Nucl. Acids Res.,25(17):3389-3402 (1977).
Babcook et al., “A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities”,Proc. Natl. Acad. Sci. USA,93(15):7843-7848 (1996).
Bird et al., “Single-Chain Antigen-Binding Proteins”,Science,242:423-426 (1988).
Bitter et al., “Expression and Secretion Vectors for Yeast”,Meth. Enzymol.,53:516-544 (1987).
Bolton et al., “The Labelling of Proteins to High Specific Radioactivities by Conjugation to a125I-Containing Acylating Agent”,Biochem J.,133:529-539 (1973).
Brennan et al., “Preparation of Bispecific Antibodies by Chemical Recombination of Monoclonal Immunoglobulin G1Fragments”,Science,229:81-83 (1985).
Broglie et al., “Light-Regulated Expression of a Pea Ribulose-1,5-Bisposphate Carboxylase Small Subunit Gene in Transformed Plant Cells”,Science,224:838-843 (1984).
Bruggemann et al., “Designer Mice: The Production of Human Antibody Repertoires in Transgenic Animals”,Year in Immunol.,7:33-40 (1993).
Capel et al., “Heterogeneity of Human IgG Fc Receptors”,Immunomethods,4:25-34 (1994).
Carlsson et al., “Protein Thiolation and Reversible Protein-Protein Conjugation”,Biochem. J.,173:723-737 (1978).
Caron et al., “Engineered humanized dimeric forms of IgG are more effective antibodies”,J. Exp. Med.,176(4):1191-1195 (1992).
Carter et al., “High LevelEscherichia coliExpression and Production of a Bivalent Humanized Antibody Fragment”,Bio/Tech.,10:163-167 (1992).
Casadevall, “Antibodies for defense against biological attack”,Nat. Biotechnol.,20:114 (2002).
Chari et al., “Immunoconjugates Containing Novel Maytansinoids: Promising Anticancer Drugs”,Cancer Res.,52:127-131 (1992).
Chothia et al., “Canonical Structures for the Hypervariable Regions of Immunoglobulins”,J. Mol. Biol.,196:901-917 (1987).
Chothia et al., “Conformations of immunoglobulin hypervariable regions”,Nature,342:877-883 (1989).
Cl

Affiliated with

Also associated with

Rating

Compositions and methods for the therapy and diagnosis of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for the therapy and diagnosis of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the therapy and diagnosis of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4264974